PRSS3 and lung adenocarcinoma: Hypothesizing that the functional significance of PRSS3 expression in lung adenocarcinoma derives from the proteolytic activity of active mesotrypsin, we next tested the ability of pharmacological inhibitors of mesotrypsin to attenuate PC9 cell invasion and proliferation.